DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.
ICYMI the AACI's Physician Clinical Leadership Initiative (PCLI) presented a two-part webinar series on hereditary cancer programs and cancer risk assessment.
Andrew Armstrong, MD, found that treatment with enzalutamide and ADT significantly reduced the risk of metastasis or death over time in men with mHSPC.
While there have been many successes with newer chemotherapies, targeted therapies, and immunotherapies, many cancer types in the human population don...
When Robert “Bob” List, 73, a retired colonel with the U.S. Marine Corps, was diagnosed with stage 2 prostate cancer, he immediately began to research the “enemy” threat.
